Clostridium difficile Recombinant Toxin A Repeating Units as a Carrier Protein for Conjugate Vaccines: Studies of Pneumococcal Type 14, Escherichia coli K1, and Shigella flexneri Type 2a Polysaccharides in Mice
Open Access
- 1 April 2000
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (4) , 2161-2166
- https://doi.org/10.1128/iai.68.4.2161-2166.2000
Abstract
Unlike the native protein, a nontoxic peptide (repeating unit of the native toxin designated rARU) from Clostridium difficile toxin A (CDTA) afforded an antigen that could be bound covalently to the surface polysaccharides of pneumococcus type 14,Shigella flexneri type 2a, and Escherichia coliK1. The yields of these polysaccharide-protein conjugates were significantly increased by prior treatment of rARU with succinic anhydride. Conjugates, prepared with rARU or succinylated (rARUsucc), were administered to mice by a clinically relevant dosage and immunization scheme. All conjugates elicited high levels of serum immunoglobulin G both to the polysaccharides and to CDTA. Conjugate-induced anti-CDTA had neutralizing activity in vitro and protected mice challenged with CDTA, similar to the rARU alone. Conjugates prepared with succinylated rARU, therefore, have potential for serving both as effective carrier proteins for polysaccharides and for preventing enteric disease caused by C. difficile.Keywords
This publication has 67 references indexed in Scilit:
- The 1996 Albert Lasker Medical Research Awards. Prevention of systemic infections, especially meningitis, caused by Haemophilus influenzae type b. Impact on public health and implications for other polysaccharide-based vaccinesJAMA, 1996
- Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine Is Immunogenic in Infants and ChildrenThe Journal of Infectious Diseases, 1995
- Perspective: Hypothesis: Serum IgG Antibody Is Sufficient to Confer Protection against Infectious Diseases by Inactivating the InoculumThe Journal of Infectious Diseases, 1995
- Polysaccharide-Protein Conjugates: A New Generation of VaccinesThe Journal of Infectious Diseases, 1990
- Immunogens consisting of oligosaccharides from the capsule of Haemophilus influenzae type b coupled to diphtheria toxoid or the toxin protein CRM197.Journal of Clinical Investigation, 1985
- The Shigella flexneri O‐antigenic polysaccharide chain Nature of the biological repeating unitEuropean Journal of Biochemistry, 1984
- Considerations for Formulating the Second-Generation Pneumococcal Capsular Polysaccharide Vaccine with Emphasis on the Cross-Reactive Types Within GroupsThe Journal of Infectious Diseases, 1983
- Structural Studies of Shigella flexneri O-AntigensEuropean Journal of Biochemistry, 1978
- Identification of Clostridium difficile as a cause of pseudomembranous colitis.BMJ, 1978
- Clindamycin-Associated Colitis Due to a Toxin-Producing Species of Clostridium in HamstersThe Journal of Infectious Diseases, 1977